SHINE touting cancer drug research results, grant from Dutch government

Early research on cancer drugs that use SHINE Technologies’ Illumira product found they could extend patients’ lifespans and more effectively treat kidney and prostate cancer, the Janesville company announced.  The business and WARF Therapeutics, the drug discovery program of the Wisconsin Alumni Research Foundation, recently released findings from research conducted at UW-Madison’s Advanced ...